Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2415-24-9
2. Catalpinoside
3. Catapol
4. Chembl513223
5. Chebi:69797
6. De(p-hydroxybenzoyl)catalposide
7. Jcx5l7jic2
8. Catalposide, Des-p-hydroxybenzoyl-
9. Einecs 219-324-0
10. Digitalis Purpurea L
11. Unii-jcx5l7jic2
12. Schembl420515
13. Catalpol, >=96% (hplc)
14. Dtxsid60178850
15. Hy-n0820
16. Zinc8234298
17. Bdbm50259972
18. Mfcd11111524
19. Akos024264429
20. Ac-8052
21. Am84820
22. Ccg-208299
23. Lmpr0102070007
24. Ncgc00163523-01
25. (1as-(1aalpha,1bbeta,2beta,5abeta,6beta,6aalpha))-1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl-beta-d-glucopyranoside
26. As-75213
27. Beta-d-glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-6-hydroxy- 1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl, (1as-(1a-alpha,1b-beta,2-beta,5a-beta,6-beta,6a-alpha))-
28. Beta-d-glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl, (1as-(1aalpha,1bbeta,2beta,5abeta,6beta,6aalpha))-
29. N1352
30. Sr-05000002315
31. Q1050267
32. Sr-05000002315-2
33. (1as,1bs,2s,5ar,6s,6as)-1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl Beta-d-glucopyranoside
34. (1s,5r,6r)-2-[(1s,1bs,2s,5ar,6s)-6-hydroxy-1a-((s)-hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydro-1,3-dioxa-cyclopropa[a]inden-2-yloxy]-6-((s)-hydroxymethyl)-tetrahydro-pyran-3,4,5-triol
35. (2s,3r,4s,5s,6r)-2-(((1as,1bs,2s,5ar,6s,6as)-6-hydroxy-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[2',3':4,5]cyclopenta[1,2-c]pyran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
36. (2s,3r,4s,5s,6r)-2-[[(1s,2s,4s,5s,6r,10s)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-10-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
37. (2s,3r,4s,5s,6r)-2-{[(1s,2s,4s,5s,6r,10s)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0(2),?]dec-7-en-10-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
Molecular Weight | 362.33 g/mol |
---|---|
Molecular Formula | C15H22O10 |
XLogP3 | -3.2 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 4 |
Exact Mass | 362.12129689 g/mol |
Monoisotopic Mass | 362.12129689 g/mol |
Topological Polar Surface Area | 162 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 542 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 11 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
47
PharmaCompass offers a list of Catalpol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Catalpol manufacturer or Catalpol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Catalpol manufacturer or Catalpol supplier.
PharmaCompass also assists you with knowing the Catalpol API Price utilized in the formulation of products. Catalpol API Price is not always fixed or binding as the Catalpol Price is obtained through a variety of data sources. The Catalpol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Catalpol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Catalpol, including repackagers and relabelers. The FDA regulates Catalpol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Catalpol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Catalpol supplier is an individual or a company that provides Catalpol active pharmaceutical ingredient (API) or Catalpol finished formulations upon request. The Catalpol suppliers may include Catalpol API manufacturers, exporters, distributors and traders.
Catalpol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Catalpol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Catalpol GMP manufacturer or Catalpol GMP API supplier for your needs.
A Catalpol CoA (Certificate of Analysis) is a formal document that attests to Catalpol's compliance with Catalpol specifications and serves as a tool for batch-level quality control.
Catalpol CoA mostly includes findings from lab analyses of a specific batch. For each Catalpol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Catalpol may be tested according to a variety of international standards, such as European Pharmacopoeia (Catalpol EP), Catalpol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Catalpol USP).